These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 16998966)

  • 1. Omalizumab for asthma.
    Tonnel AB; Tillie-Leblond I
    N Engl J Med; 2006 Sep; 355(12):1282. PubMed ID: 16998966
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of omalizumab in reducing corticosteroid burden in patients with moderate to severe persistent allergic asthma.
    Karpel J; Massanari M; Geba GP; Kianifard F; Inhaber N; Zeldin RK
    Ann Allergy Asthma Immunol; 2010 Dec; 105(6):465-70. PubMed ID: 21130385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Omalizumab, an anti-IgE monoclonal antibody to treat severe asthma].
    Michils A; Sternon J
    J Pharm Belg; 2006; 61(3):83-7. PubMed ID: 17058881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omalizumab: a second look in severe persistent asthma: new adverse effects.
    Prescrire Int; 2011 Apr; 20(115):90-2. PubMed ID: 21648207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Churg-Strauss syndrome with controlled asthma during omalizumab treatment.
    Ruppert AM; Averous G; Stanciu D; Deroide N; Riehm S; Poindron V; Pauli G; Debry C; de Blay F
    J Allergy Clin Immunol; 2008 Jan; 121(1):253-4. PubMed ID: 18206510
    [No Abstract]   [Full Text] [Related]  

  • 6. [Omalizumab. A monoclonal antibody against IgE].
    Hennemann A
    Med Monatsschr Pharm; 2004 Dec; 27(12):404-7. PubMed ID: 15646688
    [No Abstract]   [Full Text] [Related]  

  • 7. Omalizumab for asthma.
    Winchester DE; Jacob A; Murphy T
    N Engl J Med; 2006 Sep; 355(12):1281-2. PubMed ID: 16990394
    [No Abstract]   [Full Text] [Related]  

  • 8. Effectiveness of omalizumab in monozygotic twin sisters with severe allergic asthma.
    Just J; Sahraoui F; Le Gros V; Grimfeld A
    Allergy; 2007 Apr; 62(4):453-4. PubMed ID: 17362261
    [No Abstract]   [Full Text] [Related]  

  • 9. Omalizumab for asthma.
    Strunk RC; Bloomberg GR
    N Engl J Med; 2006 Jun; 354(25):2689-95. PubMed ID: 16790701
    [No Abstract]   [Full Text] [Related]  

  • 10. Patient-reported outcomes among omalizumab and salmeterol/fluticasone combination therapy patients.
    Miller DP; Tom G; Rasouliyan L; Chipps B
    J Asthma; 2009 Mar; 46(2):179-85. PubMed ID: 19253127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New drugs; omalizumab].
    Cohen AF; Dubois EA; van Bronswijk H
    Ned Tijdschr Geneeskd; 2006 Dec; 150(52):2871-2. PubMed ID: 17319219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omalizumab in children: a negative risk-benefit balance in severe persistent asthma.
    Prescrire Int; 2011 Apr; 20(115):92. PubMed ID: 21648208
    [No Abstract]   [Full Text] [Related]  

  • 13. Omalizumab administration in Churg-Strauss syndrome.
    Giavina-Bianchi P; Kalil J
    Eur J Intern Med; 2009 Oct; 20(6):e139. PubMed ID: 19782907
    [No Abstract]   [Full Text] [Related]  

  • 14. Omalizumab: overview of pharmacology and efficacy in asthma.
    Ledford DK
    Expert Opin Biol Ther; 2009 Jul; 9(7):933-43. PubMed ID: 19527111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unanswered questions on omalizumab (Xolair) patient selection and follow-up.
    Lanier B; Marshall GD
    Ann Allergy Asthma Immunol; 2004 Feb; 92(2):198-200. PubMed ID: 14989386
    [No Abstract]   [Full Text] [Related]  

  • 16. Home therapy with subcutaneous anti-immunoglobulin-E antibody omalizumab in 25 patients with immunoglobulin-E-mediated (allergic) asthma.
    Liebhaber M; Dyer Z
    J Asthma; 2007 Apr; 44(3):195-6. PubMed ID: 17454337
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study.
    Niven R; Chung KF; Panahloo Z; Blogg M; Ayre G
    Respir Med; 2008 Oct; 102(10):1371-8. PubMed ID: 18657960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omalizumab in the management of oral corticosteroid-dependent IGE-mediated asthma patients.
    Domingo C; Moreno A; José Amengual M; Montón C; Suárez D; Pomares X
    Curr Med Res Opin; 2011 Jan; 27(1):45-53. PubMed ID: 21083517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe serum sickness-like syndrome after omalizumab therapy for asthma.
    Pilette C; Coppens N; Houssiau FA; Rodenstein DO
    J Allergy Clin Immunol; 2007 Oct; 120(4):972-3. PubMed ID: 17716723
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluticason furoate (Arnuity Ellipta) for asthma.
    Med Lett Drugs Ther; 2015 May; 57(1469):76-9. PubMed ID: 25989197
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.